Duker is a founder of Hemera Biosciences, a clinical-stage biotech company developing treatments of eye disease through complement inhibition using a gene therapy delivery system that was acquired by Janssen in 2020, and the Boston Image Reading Center (BIRC). Duker is the founder of several successful businesses including the fifth busiest independent ophthalmic ambulatory surgery center in the United States, SurgiSite Boston.
#Hemera biosciences full
Duker’s current full time position is Chief Operating Officer (COO) of EyePoint Pharmaceuticals, a publicly traded biotech company that specializes in long term drug delivery to the eye. Jefferson Medical College of Thomas Jefferson University Academic AppointmentĪdjunct Professor of Ophthalmology, Tufts University School of Medicine Board Certificationġ992 – American Academy of Ophthalmology, Honor AwardĢ003 – American Academy of Ophthalmology, Senior Achievement AwardĢ010 – American Society of Retina Specialists, Honor AwardĢ013 – American Society of Retina Specialists, Senior Honor AwardĢ015 – American Academy of Ophthalmology, Life Achievement Honor AwardĢ015 – Brazilian Society of Retina and Vitreous Honor AwardĢ019 – Viki and Jack Farber Vision Research Award, Wills Eye Hospital Personal Interestsĭr. Vitreoretinal Diseases and Surgery and Intraocular Tumors, Wills Eye Hospital Residency Duker has been instrumental in discovering clinical applications of OCT technology. Novel imaging techniques of the eye, especially optical coherence tomography (OCT), drug delivery to the posterior segment, retinal vascular disorders and posterior segment uveitis. He has a particular interest in rare and unusual retinal disorders, especially those connected to systemic disease.
Duker’s part-time clinical practice is limited to medical diseases of the posterior segment of the eye including age-related macular degeneration (AMD), diabetic retinopathy, retinal vascular diseases, posterior segment uveitis, and intraocular tumors.
Through his varied ophthalmology-related activities spanning four decades of practice, he has developed a local, regional, national, and international reputation as a highly successful clinician, surgeon, diagnostician, educator, researcher, administrator, and entrepreneur. He served as the Chair of the Ophthalmology Department at Tufts between 20. is an Adjunct Professor of Ophthalmology at the Tufts Medical Center and Tufts University School of Medicine in Boston, Massachusetts.
0 kommentar(er)
